JNCE - Jounce Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5146.07M
Enterprise Value 34.33M
Trailing P/E N/A
Forward P/E 1-3.23
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)2.25
Price/Book (mrq)1.55
Enterprise Value/Revenue 30.07
Enterprise Value/EBITDA 6-0.16

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin -41.13%
Operating Margin (ttm)-47.73%

Management Effectiveness

Return on Assets (ttm)-7.92%
Return on Equity (ttm)-26.11%

Income Statement

Revenue (ttm)64.99M
Revenue Per Share (ttm)1.99
Quarterly Revenue Growth (yoy)-1.90%
Gross Profit (ttm)34.31M
EBITDA -27.17M
Net Income Avi to Common (ttm)-26.73M
Diluted EPS (ttm)-0.8170
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)163.79M
Total Cash Per Share (mrq)4.97
Total Debt (mrq)21.75M
Total Debt/Equity (mrq)23.03
Current Ratio (mrq)2.24
Book Value Per Share (mrq)2.86

Cash Flow Statement

Operating Cash Flow (ttm)-65.68M
Levered Free Cash Flow (ttm)9.36M

Trading Information

Stock Price History

Beta (3Y Monthly) 3.59
52-Week Change 3-44.19%
S&P500 52-Week Change 38.16%
52 Week High 38.5760
52 Week Low 32.6600
50-Day Moving Average 34.9109
200-Day Moving Average 34.8851

Share Statistics

Avg Vol (3 month) 3133.33k
Avg Vol (10 day) 3107.93k
Shares Outstanding 532.97M
Float 15.86M
% Held by Insiders 113.32%
% Held by Institutions 179.73%
Shares Short (May 31, 2019) 4495.91k
Short Ratio (May 31, 2019) 44.18
Short % of Float (May 31, 2019) 43.09%
Short % of Shares Outstanding (May 31, 2019) 41.50%
Shares Short (prior month Apr 30, 2019) 4463.02k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A